Iodine-125 interstitial brachytherapy for malignant tumor.
- Author:
Kai-yuan LUO
1
;
Wen-yuan MAO
;
Bo LI
;
Qing-hua SHAO
;
Yong YANG
;
Quan ZHAO
;
Rong YANG
;
Guo-kai YANG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Brachytherapy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; therapeutic use; Male; Middle Aged; Neoplasms; radiotherapy; therapy; Retrospective Studies; Treatment Outcome
- From: Chinese Journal of Surgery 2003;41(2):122-124
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo assess the clinical effects of (125)I interstitial brachytherapy for malignant tumors.
METHODSOne hundred and twelve patients with malignant tumors of stage II stage and III under went radical resection combined with (125)I intraoperative implantation. Seven days and three month after operation WBC count and immune markers were observed. Blood biochemistry ultrasonography and X-ray were performed to observe recurrence and metastasis of tumors per three months.
RESULTSIn the 112 patients, 3 died of tumor recurrence in six months, and others survived with the longest time of 35 months.
CONCLUSION(125)I interstitial brachytherapy for malignant tumor is simple, safe and effective.
